Inari Medical rises on $4.9 bln buyout by device maker Stryker

Inari Medical

07/01/2025 09:53

** Shares of Inari Medical  NARI.O  rise ~21% premarket to
$78.50 premarket 
    ** Larger rival Stryker Corp  SYK.N  late on Monday agreed
to buy NARI in an all-cash deal worth $4.9 billion
    ** The deal for NARI, which makes devices that treat
patients with venous diseases, bolsters Stryker's efforts to
expand its offerings to treat venous thromboembolism, a
condition where a blood clot forms in a vein, and other vascular
diseases
    ** As part of the deal, which was first reported by Reuters,
Stryker will pay $80 per share for Inari
    ** Up to last close, NARI stock has gained ~2% over the past
12 months

 (Reporting by Mariam Sunny in Bengaluru)
 ((Mariam.ESunny@thomsonreuters.com;))